Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals-Reference-Cited by-同舟云学术

Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals

Published:2011-03-16 Issue:7 Volume:20 Page:747-753
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Noize Pernelle¹²³⁴,Bagheri Haleh¹⁵⁶,Durrieu Geneviève¹⁵⁶,Haramburu Françoise²³⁴,Moore Nicholas²³⁴,Giraud Patrick⁷,Galinier Michel⁸,Pourrat Jacques⁹,Montastruc Jean-Louis¹⁵⁶

Affiliation:

1. CHU de Toulouse, Service de Pharmacologie Clinique; Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament; F-31000 Toulouse France

2. Univ. de Bordeaux, U657; F-33000 Bordeaux France

3. INSERM, U657; F-33000 Bordeaux France

4. CHU de Bordeaux; Service de Pharmacologie, Centre de Pharmacovigilance; F-33000 Bordeaux France

5. Univ. de Toulouse, Laboratoire de Pharmacologie Médicale et Clinique, Unité de Pharmacoépidémiologie, U1027; F-31000 Toulouse France

6. INSERM, U1027; F-31000 Toulouse France

7. Clinique du Pont-de-Chaume, Service de Néphrologie et Médecine Interne; F-82000 Montauban France

8. CHU de Toulouse, Service de Cardiologie Générale et Interventionnelle; F-31000 Toulouse France

9. CHU de Toulouse, Service de Néphrologie et Immunologie Clinique; F-31000 Toulouse France

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.2128/fullpdf

Reference31 articles.

1. Hypokalaemia and hyperkalaemia;Rastergar;Postgrad Med J,2001

2. Drug-induced hyperkalemia: old culprits and new offenders;Perazella;Am J Med,2002

3. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system;Palmer;N Engl J Med,2004

4. Low molecular weight heparins and hypoaldosteronism;Levesque;BMJ,1990

5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N Engl J Med,1999

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergency Department Presentation of Life-threatening Symptomatic Hyperkalemia From an Angiotensin Receptor Blocker in a Low-risk Individual;Military Medicine;2022-12-01

2. Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management;International Journal of Nephrology and Renovascular Disease;2022-08

3. Risk of hyperkalemia from renin–angiotensin–aldosterone system inhibitors and factors associated with treatment discontinuities in a real-world population;Nephrology Dialysis Transplantation;2019-12-17

4. Hospital‐Acquired Hyperkalemia Events in Older Patients Are Mostly Due to Avoidable, Multifactorial, Adverse Drug Reactions;Clinical Pharmacology & Therapeutics;2018-11-03

5. The Cost of Hyperkalemia in the United States;Kidney International Reports;2018-03